New York, New York, August 10, 2009: Inter Parfums, Inc. (NASDAQ GS: IPAR) today reported results for the second quarter ended June 30, 2009.
Second Quarter 2009 Compared to Second Quarter 2008:
· Net sales declined to $88.6 million or 10.6% from $99.1 million; at comparable foreign currency exchange rates, net sales were down 3% for the period;
· Sales by European-based operations were $79.4 million, down 5% from $83.9 million;
· Sales by U.S.-based operations declined 39% to $9.2 million from $15.2 million;
· Gross margin for both periods was 57%;
· S, G & A expense as a percentage of sales was 49% compared to 50%;
· Operating margins were 7.7% of sales compared to 6.9%;
· Net income attributable to Inter Parfums, Inc. rose 12% to $4.2 million from $3.8 million; and,
· Diluted earnings per share attributable to Inter Parfums, Inc. common shareholders were $0.14 compared to $0.12.
Through the first half of 2009, net sales were $179.0 million, or 19.4% below the $222.2 million reported in the first half of 2008. At comparable foreign currency exchange rates, net sales were down 13%. Net income attributable to Inter Parfums, Inc. decreased 23% to $9.7 million or $0.32 per diluted share from $12.5 million or $0.40 per diluted share in the first half of 2008.
Jean Madar,
Chairman and CEO of Inter Parfums, noted, “As we previously reported, about
6.5% of the second quarter sales decline was due to the continued strength of the
U.S. dollar relative to the euro. Also,
in the prior year period, both our European-based and
He continued, “Our new product
pipeline for the second half of the year is vibrant on both sides of the
He continued, “Brooks Brothers Black Fleece is debuting this fall. Also, two new fragrances under the Banana
Republic brand,
With regard to European-based
operations, Mr. Madar noted, “During the second quarter of 2009 we introduced
an ST Dupont fragrance for women for select distribution. Van Cleef & Arpels Collection Extraordinaire is coming to market in September as is a
new men’s scent, Paul Smith
Discussing factors impacting profitability, Russell Greenberg, Executive Vice President & CFO, pointed out, “As was the case in the first quarter, second quarter sales mix variations offset an increase in the gross margin percentage that typically accompanies a rising dollar since approximately 35% of European-based product sales are denominated in dollars while costs are incurred in euro. In response to the dramatic strengthening of the U.S. dollar during the fourth quarter of 2008, we entered into foreign currency forward exchange contracts to hedge approximately 80% of our 2009 sales scheduled to be invoiced in U.S. dollars. As a result, for the three and six months ended June 30, 2009, we recorded foreign currency gains of $2.5 million and $3.9 million, respectively, which contributed $1.2 million and $1.9 million, respectively, to net income attributable to Inter Parfums, Inc. common shareholders.”
Mr. Greenberg concluded, “Based upon our new product launch schedule, as well as the seasonality of our business, we expect a stronger second half and remain confident that we will meet our 2009 guidance which calls for net sales of $390 million, and net income attributable to Inter Parfums, Inc. common shareholders’ of approximately $21.0 million or $0.70 per diluted share, assuming the dollar remains at current levels.”
The Company’s next regular quarterly cash dividend of $.033 per share will be payable on October 15, 2009 to shareholders of record on September 30, 2009.
Conference Call
The management of Inter Parfums will host a conference call at 11:00 am EDT on Tuesday, August 11, 2009, to discuss second quarter results and other recent developments. Interested parties may participate by calling 706-679-3037, approximately 10 minutes before the start of the call. This conference call will also be distributed live over the Internet via the Investor Relations section of the Company’s web site at www.interparfumsinc.com. To listen to the live call, please go to the web site in advance to register. If you are unable to listen live, the conference call will be archived at the web site.
Inter Parfums, Inc. develops, manufactures and distributes prestige perfumes and cosmetics as the exclusive worldwide licensee for Burberry, Van Cleef & Arpels, Paul Smith, S.T. Dupont, and Quiksilver/Roxy. The Company also owns Lanvin Perfumes and Nickel, a men’s skin care company. It also produces personal care products for specialty retailers under exclusive agreements for Gap, Banana Republic, New York & Company, Brooks Brothers and bebe brands. In addition, Inter Parfums produces and supplies mass market fragrances and fragrance related products. The Company’s products are sold in over 120 countries worldwide.
Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will" and "would" or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Inter Parfums' annual report on Form 10-K for the fiscal year ended December 31, 2008 and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this press release.
Contact at Inter Parfums, Inc. or Investor Relations Counsel
Russell Greenberg, Exec. VP & CFO The Equity Group Inc.
(212) 983-2640
rgreenberg@interparfumsinc.com Lena Cati (212) 836-9611/lcati@equityny.com
www.interparfumsinc.com www.theequitygroup.com
CONSOLIDATED STATEMENTS OF INCOME
(In thousands except per share data)
(Unaudited)
|
|
|
Three Months Ended |
|
Six Months Ended |
||||
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ 88,604 |
|
$ 99,078 |
|
$ 179,013 |
|
$ 222,241 |
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
38,403 |
|
43,104 |
|
75,247 |
|
92,179 |
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
50,201 |
|
55,974 |
|
103,766 |
|
130,062 |
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
43,380 |
|
49,142 |
|
86,643 |
|
104,085 |
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
6,821 |
|
6,832 |
|
17,123 |
|
25,977 |
|
|
|
|
|
|
|
|
|
|
|
Other expenses (income): |
|
|
|
|
|
|
|
|
|
Interest expense |
|
397 |
|
376 |
|
1,709 |
|
1,447 |
|
(Gain) loss on foreign currency |
|
(2,563) |
|
(181) |
|
(3,942) |
|
186 |
|
Interest income |
|
(101) |
|
(551) |
|
(609) |
|
(1,165) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,267) |
|
(356) |
|
(2,842) |
|
468 |
|
|
|
|
|
|
|
|
|
|
|
Income
before income taxes |
|
9,088 |
|
7,188 |
|
19,965 |
|
25,509 |
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
3,335 |
|
2,698 |
|
6,956 |
|
9,882 |
|
|
|
|
|
|
|
|
|
|
Net income
|
|
5,753 |
|
4,490 |
|
13,009 |
|
15,627 |
|
|
|
|
|
|
|
|
|
|
|
Less:
Net income attributable to the noncontrolling interest |
|
1,527 |
|
718 |
|
3,355 |
|
3,147 |
|
|
|
|
|
|
|
|
|
|
Net income
attributable to
Inter
Parfums, Inc.
|
|
$ 4,226 |
|
$ 3,772 |
|
$ 9,654 |
|
$ 12,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable
to Inter Parfums, Inc. common shareholders: |
|
|
|
|
|
|
|
|
|
Basic |
|
$0.14 |
|
$0.12 |
|
$0.32 |
|
$0.41 |
|
Diluted |
|
$0.14 |
|
$0.12 |
|
$0.32 |
|
$0.40 |
|
|
|
|
|
|
|
|
|
|
|
Weighted
average number of shares outstanding: |
|
|
|
|
|
|
|
|
|
Basic |
|
30,064 |
|
30,627 |
|
30,115 |
|
30,674 |
|
Diluted |
|
30,064 |
|
30,914 |
|
30,115 |
|
30,861 |
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS
(In thousands except
share and per share data)
ASSETS
|
||||
|
|
|
June 30, 2009 |
|
December 31, |
|
|
|
(unaudited) |
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
|
$ 34,045 |
|
$ 42,404 |
|
Accounts receivable, net |
|
109,148 |
|
120,507 |
|
Inventories |
|
116,953 |
|
123,633 |
|
Receivables, other |
|
4,353 |
|
2,904 |
|
Other current assets |
|
12,400 |
|
10,034 |
|
Income tax receivable |
|
517 |
|
1,631 |
|
Deferred tax assets |
|
4,062 |
|
3,388 |
|
|
|
|
|
|
|
Total
current assets |
|
281,478 |
|
304,501 |
|
|
|
|
|
|
Equipment and leasehold
improvements, net
|
|
8,928 |
|
7,670 |
|
|
|
|
|
|
Goodwill
|
|
5,553 |
|
5,470 |
|
|
|
|
|
|
Trademarks, licenses and other
intangible assets, net
|
|
103,264 |
|
104,922 |
|
|
|
|
|
|
Other assets
|
|
972 |
|
2,574 |
|
|
|
|
|
|
|
Total assets |
|
$ 400,195 |
|
$ 425,137 |
|
|
||||
LIABILITIES AND
EQUITY
|
||||
|
Current liabilities: |
|
|
|
|
|
Loans payable – banks |
|
$ 10,489 |
|
$ 13,981 |
|
Current portion of long-term debt |
|
11,403 |
|
13,352
|
|
Accounts payable - trade |
|
48,856 |
|
66,236 |
|
Accrued expenses |
|
27,294 |
|
35,368 |
|
Income taxes payable |
|
783 |
|
442 |
|
Dividends payable |
|
992 |
|
996 |
|
|
|
|
|
|
|
Total
current liabilities |
|
99,817 |
|
130,375 |
|
|
|
|
|
|
Long-term debt, less current
portion
|
|
22,371 |
|
27,691 |
|
|
|
|
|
|
Deferred tax liability
|
|
11,379 |
|
11,562 |
|
|
|
|
|
|
Equity:
|
|
|
|
|
Inter Parfums, Inc. shareholders’ equity:
|
|
|
|
|
Preferred stock, $.001 par; authorized
|
|
|
|
|
Common stock, $.001 par; authorized 100,000,000
shares;
|
|
30 |
|
30 |
Additional paid-in capital
|
|
42,187 |
|
41,950 |
Retained earnings
|
|
175,808 |
|
168,025 |
Accumulated other comprehensive income
|
|
27,935 |
|
25,515 |
Treasury stock, at cost, 10,074,479 and 9,966,379
common
|
|
(31,950) |
|
(31,319) |
|
|
|
|
|
|
Total Inter
Parfums, Inc. shareholders’ equity
|
|
214,010 |
|
204,201 |
|
|
|
|
|
|
Noncontrolling interest
|
|
52,618 |
|
51,308 |
|
|
|
|
|
|
|
Total
equity |
|
266,628 |
|
255,509 |
|
|
|
|
|
|
Total
liabilities and equity
|
|
$ 400,195 |
|
$ 425,137 |